Search Results 1031-1040 of 17031 for ✔
A Study Of Ifinatamab Deruxtecan In Subjects With Pretreated Advanced Or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01) · Overview.
For more than a year, COVID-19 has forced people to depart from their normal routines. Physical isolation, working from home, and added stress and anxiety ...
Advancing medicine one lab test at a time featured image · Autosomal Dominant Polycystic Kidney Disease: Early intervention and lifestyle crucial featured image.
Swift MD, Molella RG, Vaughn AIS, Breeher LE, Newcomb RD, Abdellatif S, Murad MH. Determinants of Latent Tuberculosis Treatment Acceptance and Completion in ...
Millions of people worldwide are affected by alcohol use disorder, a debilitating addiction that can disrupt daily life and overall health. Alcohol use disorder ...
Considered the most aggressive type of brain cancer, glioblastoma grows rapidly, destroying healthy tissue. Globally, approximately 300,000 people are diagnosed ...
This is a single-arm, two-stage, phase II trial to assess the efficacy of futibatinib plus pembrolizumab in advanced hepatocellular carcinoma for patients with ...
Latest stories · Mayo Clinic smartwatch study reveals new path to boosting physician well-being featured image · Mayo Clinic researchers discover the immune ...
2023 Gerstner Awardee's 'evolutionary therapy' targets pancreatic cancer treatment resistance featured image · 2023 Gerstner Awardee to investigate ...
Latest stories · When the body attacks the brain: Immune system often to blame for encephalitis, study · Science Saturday: Direct to consumer genetic testing ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!